What does APOTHEEK VIAENE do?

APOTHEEK VIAENE is a pharmacy in Deerlijk. Private Limited, started on 3 May 2004, 1 establishment.

What is the address of APOTHEEK VIAENE?

The registered office of APOTHEEK VIAENE is located at Driesknoklaan 25, 8540 Deerlijk.

Is APOTHEEK VIAENE still active?

Yes. According to the CBE (30 October 2026) APOTHEEK VIAENE is active, legal situation “Normale toestand”, started on 3 May 2004.

Is APOTHEEK VIAENE registered on Peppol?

Yes, APOTHEEK VIAENE is registered on the Peppol network with ID 0208:0865063717.

What is the enterprise number of APOTHEEK VIAENE?

The enterprise number of APOTHEEK VIAENE is BE0865063717.

When was APOTHEEK VIAENE founded?

APOTHEEK VIAENE was founded on 3 May 2004.

Who are the directors of APOTHEEK VIAENE?

According to the 2025 annual accounts, the directors of APOTHEEK VIAENE are: Mipharma bv, Thibault D'heygere.

Is APOTHEEK VIAENE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 May 2004; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK VIAENE make in 2025?

APOTHEEK VIAENE posted a profit after taxes of € 38,566 in financial year 2025.

What is the revenue of APOTHEEK VIAENE?

As a small company, APOTHEEK VIAENE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 223,019.

How much does an employee at APOTHEEK VIAENE earn?

The average wage cost per full-time employee at APOTHEEK VIAENE was € 63,200 in 2025: staff costs of € 101,168 for 1.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK VIAENE have?

According to the 2025 annual accounts, APOTHEEK VIAENE has 1.6 full-time equivalents (FTE).

APOTHEEK VIAENE (Private Limited) - Deerlijk

Dossier APOTHEEK VIAENE, printed on 30 October 2026 from databakkes.be/en/0865063717/apotheek-viaene. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK VIAENE from Deerlijk, company number BE0865063717, closed financial year 2025 with a result of € 38,566 after tax. For that financial year APOTHEEK VIAENE recorded a gross margin of € 223,019 and equity of € 638,064. Compared with financial year 2024, the result moved from € 36,795 to € 38,566. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.

What it is worth Growing

€ 638,064

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 38,566

▲ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 37,340

▼ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 619,464.

People and assets in 2025

Full-time equivalents

1.6

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 101,168

▲ 13% vs 2024

€ 63,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 237,705

▲ 6% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 274,586

▼ 5% vs 2024

€ 35,477 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 72,761

▼ 25% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 14,653

▼ 22% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 186,491 Gross margin 2022: € 186,491 First fiscal year in the series	€ 201,037 Gross margin 2023: € 201,037 ▲ 8% vs 2022 (€ 186,491) Favourable step	€ 211,870 Gross margin 2024: € 211,870 ▲ 5% vs 2023 (€ 201,037) Favourable step	€ 223,019 Gross margin 2025: € 223,019 ▲ 5% vs 2024 (€ 211,870) Favourable step	▲ 5%
Profit after taxes	€ 56,543 Profit after taxes 2022: € 56,543 First fiscal year in the series	€ 37,774 Profit after taxes 2023: € 37,774 ▼ 33% vs 2022 (€ 56,543) Unfavourable step	€ 36,795 Profit after taxes 2024: € 36,795 ▼ 3% vs 2023 (€ 37,774) Unfavourable step	€ 38,566 Profit after taxes 2025: € 38,566 ▲ 5% vs 2024 (€ 36,795) Favourable step	▲ 5%
Equity	€ 524,928 Equity 2022: € 524,928 First fiscal year in the series	€ 562,702 Equity 2023: € 562,702 ▲ 7% vs 2022 (€ 524,928) Favourable step	€ 599,497 Equity 2024: € 599,497 ▲ 7% vs 2023 (€ 562,702) Favourable step	€ 638,064 Equity 2025: € 638,064 ▲ 6% vs 2024 (€ 599,497) Favourable step	▲ 6%
Total debts	€ 410,453 Total debts 2022: € 410,453 First fiscal year in the series	€ 458,161 Total debts 2023: € 458,161 ▲ 12% vs 2022 (€ 410,453) Unfavourable step	€ 469,909 Total debts 2024: € 469,909 ▲ 3% vs 2023 (€ 458,161) Unfavourable step	€ 483,229 Total debts 2025: € 483,229 ▲ 3% vs 2024 (€ 469,909) Unfavourable step	▲ 3%
Cash	€ 16,358 Cash 2022: € 16,358 First fiscal year in the series	€ 23,959 Cash 2023: € 23,959 ▲ 46% vs 2022 (€ 16,358) Favourable step	€ 42,663 Cash 2024: € 42,663 ▲ 78% vs 2023 (€ 23,959) Favourable step	€ 37,340 Cash 2025: € 37,340 ▼ 12% vs 2024 (€ 42,663) Unfavourable step	▼ 12%
Land & buildings	€ 280,169 Land & buildings 2022: € 280,169 First fiscal year in the series	€ 267,401 Land & buildings 2023: € 267,401 ▼ 5% vs 2022 (€ 280,169) Unchanged	€ 254,634 Land & buildings 2024: € 254,634 ▼ 5% vs 2023 (€ 267,401) Unchanged	€ 241,866 Land & buildings 2025: € 241,866 ▼ 5% vs 2024 (€ 254,634) Unchanged	▼ 5%
Retained profit	€ 506,328 Retained profit 2022: € 506,328 First fiscal year in the series	€ 544,102 Retained profit 2023: € 544,102 ▲ 7% vs 2022 (€ 506,328) Favourable step	€ 580,897 Retained profit 2024: € 580,897 ▲ 7% vs 2023 (€ 544,102) Favourable step	€ 619,464 Retained profit 2025: € 619,464 ▲ 7% vs 2024 (€ 580,897) Favourable step	▲ 7%
Bank debt	€ 296,359 Bank debt 2022: € 296,359 First fiscal year in the series	€ 329,185 Bank debt 2023: € 329,185 ▲ 11% vs 2022 (€ 296,359) Unfavourable step	€ 287,806 Bank debt 2024: € 287,806 ▼ 13% vs 2023 (€ 329,185) Favourable step	€ 274,586 Bank debt 2025: € 274,586 ▼ 5% vs 2024 (€ 287,806) Favourable step	▼ 5%
Balance sheet total	€ 935,381 Balance sheet total 2022: € 935,381 First fiscal year in the series	€ 1,020,863 Balance sheet total 2023: € 1,020,863 ▲ 9% vs 2022 (€ 935,381) Unchanged	€ 1,069,407 Balance sheet total 2024: € 1,069,407 ▲ 5% vs 2023 (€ 1,020,863) Unchanged	€ 1,121,293 Balance sheet total 2025: € 1,121,293 ▲ 5% vs 2024 (€ 1,069,407) Unchanged	▲ 5%
Employees (FTE)	0 Employees (FTE) 2022: 0 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 Unchanged (0) Unchanged	1.7 Employees (FTE) 2024: 1.7 Unchanged (1.7) Unchanged	1.6 Employees (FTE) 2025: 1.6 ▼ 0.1 vs 2024 (1.7) Unchanged	▼ 0.1

Key figures of APOTHEEK VIAENE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK VIAENE?

What happened at APOTHEEK VIAENE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 24, 2026 New annual accounts for financial year 2025: profit of € 38,566 (▲ 5% vs 2024). filed late Source: NBB ↗
May 3, 2004 New establishment in Deerlijk. KBO
May 3, 2004 Start of the company according to the CBE. KBO

In short

From € 56,543 profit in 2022 to € 38,566 profit in 2025.

Paid € 54,402 in corporate taxes since 2022.

Best year ever: 2022, with € 56,543 profit.

On average € 139,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Mipharma 99%

The stake of Mipharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK VIAENE

Behind APOTHEEK VIAENE are Mipharma bv and Thibault D'heygere. The shares are held by Mipharma (99%).

Directors

According to the 2025 annual accounts

Mipharma bv

Director

Thibault D'heygere

Director

Also active at: TANDARTSENKABINET D'HEYGERE, Thidenta, Mipharma, Vithident

Shareholders

Mipharma

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Driesknoklaan 25

8540 Deerlijk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Thidenta same network

€ 253,917 gross margin · 2025

Mipharma same network

€ 58,706 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0865.063.717

VAT number

BE 0865.063.717

Registered office

Driesknoklaan 25, 8540 Deerlijk

Names & denominations

APOTHEEK VIAENE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

3 May 2004

Peppol

Active · Active since 3 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VIAENE

Financials

What happened to APOTHEEK VIAENE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions